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People with mental illness face stigma and discrimination,1,2 and
public stigma has not decreased during recent decades.3 Many
people with mental illness internalise public negative attitudes,
resulting in self-stigma. Self-stigma and its consequences have
been conceptualised as the opposite of empowerment;4,5 self-
stigma is associated with a number of negative outcomes such
as giving up life goals,6 social withdrawal, keeping one’s mental
illness secret7 and perception of stigma as a threat and stressor that
exceeds one’s coping resources.8,9 Initial evidence suggests that
psychoeducational, cognitive–behavioural or narrative inter-
ventions can reduce self-stigma.10–16 Since these approaches often
only have small to medium effects10 and since disclosure has been
proposed as an alternative approach to reduce stigma’s negative
impact, Coming Out Proud (COP) was developed as a manualised
peer-led group intervention that takes a new approach to reduce
stigma’s negative impact on individuals with mental illness. Based
on findings among individuals from sexual minorities and among
people with mental illness that secrecy can be a harmful coping
strategy and that disclosure or ‘coming out’ can reduce self-
stigma,7,17–20 Corrigan and colleagues developed COP as a
three-session intervention that focuses on three topics, one per
session: (a) risks and benefits of secrecy and disclosure in different
settings; (b) levels of disclosure, between the extremes of social
withdrawal/secrecy and broadcasting one’s experience with mental
illness; and (c) on helpful ways to tell one’s story with mental
illness, again in different settings. Coming Out Proud aims to
empower individuals to make a personal choice, whether or not
they decide to disclose.21,22 So far, empirical data on COP’s
feasibility and efficacy are lacking. We therefore conducted a pilot
randomised controlled trial (RCT) with the aim of investigating
(a) the feasibility of recruiting and retaining people with mental
illness to a COP trial, and (b) COP’s efficacy to reduce self-stigma,
stigma stress, disclosure-related distress and secrecy as well as
to increase empowerment, perceived benefits of being out and
disclosure-related self-efficacy.
Method
Study design and participants
Our intention-to-treat parallel randomised pilot trial compared
the COP intervention, combined with treatment as usual (TAU),
with a control group that received only TAU. The type of TAU
was not prespecified. All individuals were informed that study
participation would neither require current mental health service
use nor interfere with any treatment. The majority of participants
received psychotherapy and pharmacotherapy during the time of
the study.
We recruited participants in the region of Zu¨rich, Switzerland,
between October 2012 and March 2013. Inclusion criteria were: at
least one self-reported current Axis I or Axis II disorder according
to DSM-IV;23 age 18 or above; sufficient German language skills;
at least a moderate level of self-reported disclosure-related distress
(score 4 or higher on the screening item ‘In general, how
distressed or worried are you with respect to secrecy or
disclosure of your mental illness to others?’, rated from 1, not at
all, to 7, very much). Exclusion criteria were current in-patient
status; organic disorder, dementia or intellectual disability; or
self-reported diagnosis of only a substance- or alcohol-related
disorder, without non-substance-related current psychiatric
comorbidity, since disclosure of substance use disorders is not a
focus of COP. The regional Zu¨rich Ethics Committee approved
the trial and all participants provided written consent after being
391
Efficacy of Coming Out Proud to reduce stigma’s
impact among people with mental illness:
pilot randomised controlled trial
Nicolas Ru¨sch, Elvira Abbruzzese, Eva Hagedorn, Daniel Hartenhauer, Ilias Kaufmann, Jan Curschellas,
Stephanie Ventling, Gianfranco Zuaboni, Rene´ Bridler, Manfred Olschewski, Wolfram Kawohl,
Wulf Ro¨ssler, Birgit Kleim and Patrick W. Corrigan
Background
Facing frequent stigma and discrimination, many people
with mental illness have to choose between secrecy and
disclosure in different settings. Coming Out Proud (COP),
a 3-week peer-led group intervention, offers support
in this domain in order to reduce stigma’s negative
impact.
Aims
To examine COP’s efficacy to reduce negative stigma-related
outcomes and to promote adaptive coping styles (Current
Controlled Trials number: ISRCTN43516734).
Method
In a pilot randomised controlled trial, 100 participants with
mental illness were assigned to COP or a treatment-as-usual
control condition. Outcomes included self-stigma,
empowerment, stigma stress, secrecy and perceived benefits
of disclosure.
Results
Intention-to-treat analyses found no effect of COP on
self-stigma or empowerment, but positive effects on stigma
stress, disclosure-related distress, secrecy and perceived
benefits of disclosure. Some effects diminished during the
3-week follow-up period.
Conclusions
Coming Out Proud has immediate positive effects on
disclosure- and stigma stress-related variables and may thus
alleviate stigma’s negative impact.
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fully informed about study procedures. The trial is registered with
Current Controlled Trials: ISRCTN43516734.
The study was advertised using leaflets and posters in
psychiatric in- and out-patient departments as well as in
mutual-help group offices, supported employment services,
sheltered employment and housing sites for people with mental
illness in the Zu¨rich region. Interested individuals could contact
study staff by telephone or email. In an initial telephone screening,
inclusion and exclusion criteria were checked and any questions
answered. Interested and eligible individuals were then invited
to attend a baseline assessment. Assessments and COP groups
took place in the offices of an out-patient clinic of Psychiatric
University Hospital Zu¨rich, in the city centre and separate from
the main hospital building.
Sample size
Since previous reviews of anti-stigma interventions found small-
to medium-effect sizes10,24 and in the absence of any prior data
on COP’s efficacy, we expected a medium-effect size (equalling
d=0.5 or partial Z2 = 0.1, with a= 0.05 and b= 0.80). On this
basis and aiming for a feasible sample size, we planned with 60
per group regarding the pre–post change of our primary outcome,
self-stigma. During the course of the study, we encountered two
difficulties with reaching the planned number of participants.
First, several peers were trained to facilitate COP groups, but
dropped out before or after administering their first group
because they were too busy or unwell, resulting in two peers
alone (S.V. and J.C.) facilitating all but one group. Second,
recruitment was slower than expected. We therefore decided to
end recruitment at n=100.
Randomisation
Immediately after completing the baseline assessment (T0),
participants were randomly assigned to the intervention (COP)
or control group. We used a random-number table and, before
the study began, one number after the other was put in one
opaque envelope each. Envelopes were sequentially numbered
from 1 to 120. Once a participant had completed the baseline
assessment, a research assistant (E.H., D.H. or I.K.) opened the
next consecutively numbered envelope. Research assistants had
no knowledge which number was in each envelope. Equal numbers
indicated the COP intervention and unequal numbers the control
group. Once the envelope was opened, the research assistant
informed the participant whether she or he was assigned to the
control or COP group.
Intervention
Coming out Proud is a manualised group intervention that
consists of three lessons, each delivered in one 2 h session per week
over a 3-week period. It is COP’s aim to support people with
mental illness in their decision regarding disclosure and secrecy
in different settings. It is not the aim to make them disclose their
condition, but to assist them in finding the solution that is right
for them. The manual and workbook for COP were developed
by Corrigan and colleagues based on a previous book21 and are
available online (www.stigmaandempowerment.org/resources).
The Zu¨rich-based team of the current study translated both texts
into German (N.R., E.A., E.H., D.H., I.K., B.K.; and A.I., see
acknowledgement). All participants in the COP group received a
copy of the workbook. Groups consisted of six to ten participants;
all groups but one were facilitated by two peers (S.V. and J.C.).
Peers had previous experience either as peer counsellors in
psychiatric settings or with facilitating mutual-help groups. Before
the start of the study, each pair of facilitating peers were trained
with the workbook and ran a practice group to achieve a fidelity
score of at least 80% (see below for fidelity measurement). After
the practice groups had been run we finalised the translation
and layout of the workbook together with the peers (S.V. and
J.C.), including the German title of the programme (‘In Wu¨rde
zu sich stehen’).
Details of the COP intervention can be found in the workbook
(see above). In brief, COP’s first lesson is about the pros and cons
of disclosing. Participants discuss their idea of identity and mental
illness so that they can decide how to frame their identity. They
discuss how secrets are a part of everyone’s lives so that they
can decide whether their experiences with mental illness should
or should not be disclosed. They also weigh costs and benefits
of coming out in different settings to facilitate a decision on
whether to disclose. The second lesson is about different ways to
disclose. In this part, participants discuss levels of (non)disclosure,
ranging from social avoidance and complete secrecy to
indiscriminant disclosure and broadcasting one’s experience; this
includes weighing costs and benefits of each choice in different
settings. Participants learn how to assess whether others are
beneficial to disclose to and how to respond to the reactions of
others. Finally, participants discuss how others might respond to
their disclosure and how that will affect them. In the third lesson,
participants learn how to tell their story in a personally
meaningful way, how to identify peers who might help them with
the coming out process, to review how telling their story felt and
finally to put together all they learnt. All lessons are accompanied
by stories and worksheets in the workbook. Note that in our pilot
trial, and different from COP as written for the USA, group
facilitators were free whether or not to discuss consumer-operated
or peer-led mental health service programmes in lesson three,
because these programmes are less known in Switzerland.
Fidelity
We designed a fidelity measure for the COP programme that
consisted of 18 items for lesson one, and 10 items each for lesson
two and lesson three. Each item corresponded to a section of the
workbook, including the explanation of the overall goal of COP
and the introduction of group facilitators and participants in
the first lesson. Research assistants were present during each
COP lesson and checked the number of items/topics covered in
each lesson. In all groups, fidelity was high with scores between
17 and 18 items (94 and 100%) for lesson one, and between
9 and 10 (90 and 100%) for lessons two and three.
Outcome measures
All outcomes were assessed at three time points: at baseline (T0);
3 weeks later or after the last COP lesson for participants in the
COP group (T1); and at 3-week follow-up, i.e. 6 weeks after
baseline (T2). The internal consistency of all self-report scales
was assessed using Cronbach’s alpha values based on the current
study, with values 40.90 considered excellent, 40.80 good and
40.70 acceptable. Self-stigma was assessed by the 29-item
Internalized Stigma of Mental Illness Inventory, with higher mean
scores between 1 and 4 indicating more self-stigma.25 Because
internal consistency of the five-item stigma resistance subscale
was poor (Cronbach’s alphas 0.60, 0.52 and 0.58 for T0, T1 and
T2 respectively), we excluded these five items from the total score
(alpha of 0.92 for T0, T1 and T2). We also assessed several
secondary outcomes. First, we measured empowerment as the
conceptual opposite to self-stigma and its consequences,4 using
the 28-item Empowerment Scale,26 with a mean score between
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1 and 4 and higher scores indicating stronger empowerment
(alphas 0.81, 0.83 and 0.82 for T0, T1 and T2). Because COP is
about choosing between secrecy and disclosure, we assessed the
tendency to keep one’s mental illness a secret in order to avoid
discrimination, using Link’s 5-item secrecy scale,7 with higher
mean scores between 1 and 6 equalling more secrecy (alphas:
0.74, 0.73 and 0.72). Perceived benefits of disclosure or ‘being
out’ are an important motivation to disclose. Among those
participants who had decided to disclose to friends and family,
we therefore measured perceived benefits of being out by seven
items of the Coming Out with Mental Illness Scale (alphas: 0.76,
0.78 and 0.77), with higher means between 1 and 7 reflecting more
perceived benefits of disclosure.19
Because stigma in general can be a stressor for people with
mental illness with harmful consequences9,27 and both disclosure
and secrecy can be understood as behaviours to cope with this
stressor,22,28 we measured the cognitive appraisal of stigma as a
stressor using a previously validated eight-item measure8,9,29 that
is based on Lazarus & Folkman’s30 conceptualisation of stress
appraisal processes. Four items assessed the primary appraisal of
mental illness stigma as harmful (alphas: 0.90, 0.91 and 0.90)
and four items the secondary appraisal of perceived resources to
cope with stigma (alphas: 0.77, 0.85 and 0.81). As in previous
studies,8,9,29–31 a single stress appraisal score was computed by
subtracting perceived resources to cope from perceived harmfulness.
This score indicates the cognitive appraisal of stigma as stressful
and as exceeding personal coping resources, higher scores
equalling more stigma stress. In addition to stigma-related stress
in general, we examined disclosure-related distress in particular
using the above-mentioned screening item at baseline (T0), post
(T1) and follow-up (T2). One item assessed disclosure-related
self-efficacy, rated from 1 to 7 with higher scores indicating higher
self-efficacy (‘Regarding the secrecy or disclosure of my mental
illness, I am confident to handle all questions and issues and to
make the right choices’, rated from 1, not at all, to 7, very much).
Finally, not as an outcome measure but as a possible confounding
variable, depressive symptoms were assessed using the 15-item
German version of the Center for Epidemiologic Studies Depression
Scale32 at baseline (alpha: 0.92), with higher mean scores between
1 and 4 indicating more depressive symptoms.
Statistical methods
Baseline characteristics of the COP and control groups were
compared using t-tests for independent samples and chi-squared
tests. We examined the effects of COP as compared with the
control condition by 263 ANOVAs including group (COP v.
TAU) as between- and time (T0, T1, T2) as within-subject factor.
In case of significant or trend-level (P50.10) group6time
interactions, we ran 262 post-hoc ANOVAs for this outcome
(two groups, two measurements: T0 and T1; T1 and T2) to
determine whether there were significant group6time interactions
during the intervention period (T0/T1) and/or during follow-up
(T1/T2). Effect size estimates are provided as partial Z
2 values with
Z2 = 0.10 indicating a medium-effect size.33 All analyses were run
in SPSS, version 20 for Windows. No adjustment was made for
multiple tests, and results were considered significant at two-tailed
P50.05.
Results
Feasibility of recruitment, assessment and baseline
characteristics
Six part-time research workers recruited 100 participants during
half a year. We were contacted by 171 individuals of whom 100
were included and randomised (Fig. 1). We obtained data from
all participants at baseline (T0), post (T1) data for 86 (86%)
participants and at 3-week follow-up (T2) data for 87 (87%) of
all participants; 13 (13%) participants were lost to follow-up.
Sociodemographic and clinical variables are reported in Table 1
and did not differ significantly between the COP and the control
group. A large majority in both groups received psychotherapeutic
and psychopharmacological treatment. There were no significant
group differences in outcome variables at baseline (means
provided in Table 2; results of t-tests for independent samples
not shown: all P40.14). No adverse events occurred during the
time of the study.
Effect of COP on primary and secondary outcomes
Using analysis of variance to test for group6time interactions, we
did not detect an intervention effect on self-stigma as our primary
outcome (Table 2). In terms of secondary outcomes, there was no
significant effect of COP on empowerment or on disclosure-
related self-efficacy. However, COP led to a significant pre–post
(T0/T1) decrease of stigma stress and secrecy as compared with
the control group, with a medium-effect size for stigma stress
reduction. This effect was only partly sustained during the 3-week
follow-up period. Disclosure-related distress decreased significantly
in the COP group between baseline and post-measurement and
decreased further during the follow-up period. The intervention
increased the perceived benefits of being out, an effect that
remained stable over the follow-up period.
Comparison of those who completed
with those who dropped out of the COP group
Ten participants were lost to follow-up in the COP group (Fig. 1).
We compared these 10 with the 40 participants in that group who
completed the programme regarding baseline variables, both in
terms of sociodemographic and clinical variables (as listed in
Table 1) and of baseline scores of outcome variables (as detailed
in Table 2). We found no significant subgroup differences except
that the 10 participants who discontinued the study were younger
(mean 34.2 years, s.d. = 11.9) and reported lower disclosure-
related self-efficacy at baseline (mean 2.8 years, s.d.= 1.4) than the
40 who completed the programme (age: mean 45.1 years, s.d. =
12.1, t=72.55, P= 0.01; self-efficacy: mean 4.6 years, s.d. = 1.6,
t=73.26, P=0.002).
Participants’ views on COP
Although we did not systematically collect qualitative data, peers
(S.V. and J.C.) and research assistants (E.H., D.H. and I.K.) received
ample feedback from participants on the COP programme, which
we summarise here. Participants saw a number of strengths and
weaknesses. They particularly liked the group setting and thus
the opportunity to exchange thoughts about secrecy and
disclosure with other individuals with similar experiences; this
exchange helped many participants realise that they were not
alone in their struggle with stigma and disclosure. Participants
thought it was crucial that groups were facilitated by peers
(rather than by mental health professionals) because peers have
first-hand experience with coming out. Participants felt that
COP’s content was clear and relevant for their daily lives and
disclosure-related decisions. Many participants thought the
most helpful part was weighing the pros and cons of disclosure
v. secrecy in different settings, because it helped to move
beyond global statements (for example seeing disclosure as
‘good’ or ‘bad’) towards differentiating and finding one’s
personal view on whether or not to disclose in a particular
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situation at a particular time. In general, many felt that COP
gave them the opportunity to thoroughly think about and
discuss topics that mattered to them but that they had found
little time to reflect about before, especially because unlike in
clinical settings COP’s focus was not on symptoms or deficits
but rather on how to handle disclosure and secrecy in everyday
settings. Finally, many participants told us that they were able
to apply COP’s lessons to situations in their daily lives during
the intervention.
People also noted a number of weaknesses and difficulties.
First of all, some participants in the intervention group felt the
demand on their time because of the group sessions and
assessments was too high. Others felt that the workbook of
65 pages, which was handed out to them at the start in one piece,
was too long (it may help in the future to hand out a third of the
workbook at the start of each lesson). Some participants thought
the three lessons included too much material for the limited time
available and would have preferred a slightly longer intervention
or a briefer workbook. Some found the initial discussion of mental
illness identity difficult, and wondered whether self-labelling as
having a particular mental illness was necessary and how it could
be reconciled with current approaches to recovery. The cognitive
approach to correcting self-stigma during the first lesson (when
participants are asked to reconsider negative self-statements in
order to reduce self-stigma) was sometimes felt to be too brief.
Few participants mentioned that they had actually done
homework assignments listed in the workbook (for example
practising disclosure between sessions). Finally, some participants
felt that the preparation, during the third session, for speaking out
in public about one’s mental illness was a step too soon, at least by
European standards compared with the USA.
Discussion
Feasibility
Our study suggests it is feasible to recruit and retain adults with
mental illness to an RCT of the COP programme. We recruited
83% (100 of 120) of our target sample and retained nearly 90%
(87 of 100) throughout the trial. More participants dropped out
in the COP group, possibly because with evening sessions plus
assessments it made higher demands on the time of participants
compared with the control group. Retaining a sufficient number
of trained peers as group facilitators was a challenge.
COP’s efficacy
The intervention did not have a significant effect on our primary
outcome, with self-stigma slightly decreasing over time in both
groups. We found a corresponding pattern for empowerment, a
secondary outcome and the conceptual opposite of self-stigma
and its consequences, which slightly increased in both groups
between baseline and follow-up. On the other hand, between
baseline and post-intervention 3 weeks later COP had significant
positive effects on the cognitive appraisal of stigma as a stressor,
on disclosure-related distress, perceived benefits of disclosure
and on secrecy.
To make sense of this pattern of preliminary findings, we can
distinguish three types of outcomes: self-stigma/empowerment;
stress-related variables; and secrecy/disclosure as process
variables. First, self-stigma and empowerment are broad and
likely more stable outcomes. As a three-session intervention,
COP may have a too small therapeutic dose to achieve fast
394
171 participants
assessed for eligibility
100 randomised
71 excluded:
29 did not meet inclusion criteria
(22 low level of disclosure-related distress; 4 current
in-patient treatment; 1 no mental illness; 1 only substance-
related disorder; 1 poor German language skills)
42 unwilling to participate
(30 uninterested; 10 too busy; 2 unwell)
50 allocated to COP intervention
47 received intervention (31 three sessions;
12 two sessions; 4 one session), 3 did not
receive intervention (did not attend)
10 lost to follow-up
8 refused, 2 uncontactable
50 analysed
(T0-data complete, 11 missing
T1-data, 10 missing T2-data)
50 allocated to control
3 lost to follow-up
2 refused, 1 uncontactable
50 analysed
(T0-data complete, 3 missing
T1-data, 3 missing T2-data)
6
7
6
6
6
6
6
6
Fig. 1 Flow chart of participants.
COP, Coming Out Proud; T0, baseline; T1, 3 weeks after baseline; T2, 3-week follow-up, 6 weeks after baseline.
Reducing the impact of stigma among people with mental illness
changes in these domains. Indirect support for this assertion can
be drawn from the fact that interventions with some empirical
support to reduce self-stigma consist of a larger number of
sessions.11,13,15
Second and with respect to stress-related variables, COP had
significant positive effects on the cognitive appraisal of stigma as
a stressor; after 3 weeks, participants in the intervention group
were more likely to feel they had the necessary coping resources
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Table 1 Baseline characteristics of participants
Coming Out Proud group
(n=50)
Control group
(n=50) t-test w2 P
Sociodemographic variables
Age, years: mean (s.d.) 42.9 (12.7) 41.0 (9.8) 0.82 0.41
Female, n (%) 31 (62) 28 (56) 0.37 0.69
Ethnicity, White: n (%) 49 (98) 49 (98) 0 1
Education, years: mean (s.d.) 14.3 (2.7) 15.1 (3.6) 71.17 0.25
Living alone, n (%) 32 (64) 26 (52) 1.48 0.31
Married or stable relationship, n (%) 19 (38) 17 (34) 0.17 0.84
Born in Switzerland, n (%) 42 (84) 39 (78) 0.59 0.61
Current disability benefits, n (%) 26 (52) 22 (44) 0.64 0.55
Current competitive employment, n (%) 11 (22) 8 (16) 0.59 0.61
Clinical and diagnostic variables
Depressive symptoms, mean (s.d.)a 2.3 (0.7) 2.3 (0.7) 0.21 0.84
Years since first diagnosis, mean (s.d.) 14.1 (11.1) 10.6 (10.6) 1.62 0.11
Number of previous psychiatric in-patient treatments, mean (s.d.) 3.4 (3.5) 2.8 (3.1) 0.98 0.33
Depressive disorder, n (%) 28 (56) 32 (64) 0.67 0.54
Bipolar disorder, n (%) 9 (18) 11 (22) 0.25 0.80
Schizophrenia spectrum disorder, n (%) 16 (32) 11 (22) 1.27 0.37
Current psychiatric medication, n (%) 46 (92) 40 (80) 2.99 0.15
Current counselling/psychotherapy, n (%) 42 (84) 44 (88) 0.33 0.77
Disclosure
Disclosed mental illness to friends and family, yes: n (%)b 39 (78) 38 (76) 0.06 0.81
Disclose mental illness to people at work/school/training:c mean (s.d.) 2.8 (2.0) 2.7 (1.5) 70.29 0.77
a. Measured using the Center for Epidemiologic Studies Depression Scale, German version.32
b. Measured using the Coming Out with Mental Illness Scale.19
c. Measured with one item: ‘At work, school, university or training, I tell . . . ’, rated from 1 (‘ . . . nobody about my mental illness and keep it as secret as I can’) to 7 (‘ . . . everybody
about my mental illness and do not try to keep it a secret at all’); based on 81 participants, because 19 responded ‘not applicable’.
Table 2 Change of outcome scores for Coming Out Proud (COP) programme and control groups over time, analyses of variance
Group6time interaction
Mean (s.d.) T06T16T2 (263) T06T1 (262) T16T2 (262)
Outcome Baseline (T0) Post (T1) Follow-up (T2) F(2) partial Z
2 P F(1) partial Z2 P F(1) partial Z2 P
Self-stigmaa 0.07 0.002 0.94 – –
COP group 2.14 (0.57) 2.12 (0.53) 2.08 (0.57)
Control group 2.23 (0.55) 2.18 (0.53) 2.16 (0.50)
Empowermentb 0.74 0.02 0.48 – –
COP group 2.84 (0.31) 2.91 (0.30) 2.90 (0.32)
Control group 2.79 (0.35) 2.83 (0.35) 2.87 (0.33)
Stigma stressc 7.06 0.15 0.001 9.44 0.10 0.003 10.76 0.12 0.002
COP group 70.44 (2.28) 71.34 (2.28) 70.91 (2.37)
Control group 70.76 (2.03) 70.23 (1.85) 70.98 (2.09)
Disclosure-related distressd 2.44 0.06 0.09 4.84 0.05 0.03 0.51 0.01 0.48
COP group 5.10 (1.64) 4.47 (1.61) 4.31 (1.73)
Control group 4.85 (1.63) 4.98 (1.69) 4.57 (1.68)
Disclosure-related self-efficacye 0.11 0.001 0.89 – –
COP group 4.68 (1.53) 4.61 (1.41) 4.66 (1.48)
Control group 4.06 (1.67) 4.15 (1.72) 4.21 (1.71)
Secrecyf 2.51 0.06 0.09 4.78 0.05 0.03 0.17 0.002 0.68
COP group 4.62 (1.01) 4.41 (0.88) 4.32 (0.84)
Control group 4.44 (0.90) 4.53 (0.99) 4.37 (0.98)
Perceived benefits of disclosureg 4.70 0.15 0.01 2.91 0.05 0.09 1.25 0.02 0.27
COP group 4.15 (1.29) 4.71 (1.04) 4.94 (0.95)
Control group 4.42 (1.16) 4.53 (1.19) 4.36 (1.28)
T0, baseline; T1, 3 weeks after baseline; T2, 3-week follow-up, 6 weeks after baseline.
a. Measured using the Internalized Stigma of Mental Illness Inventory.25
b. Measured using the Empowerment Scale.26
c. Measured using the Stigma Stress Scale.8,9
d. Measured with one item: ‘In general, how distressed or worried are you with respect to secrecy or disclosure of your mental illness to others?’, rated from 1, not at all, to 7, very much.
e. Measured with one item: ‘Regarding the secrecy or disclosure of my mental illness, I am confident to handle all questions and issues and to make the right choices’, rated from 1,
not at all, to 7, very much.
f. Measured using the Stigma Coping Orientation Scale.7
g. Measured using the Coming Out with Mental Illness Scale.19
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to handle stigma-related threats. This is a preliminary but
encouraging finding, because stigma stress is a key reaction of
stigmatised individuals facing the threat of discrimination and is
associated with a wide range of negative long-term outcomes.9,27
Decreased stigma stress, if sustained over time, along with reduced
disclosure-related distress is therefore likely to translate to reduced
self-stigma9,31 and other positive outcomes. Future research
should investigate whether booster sessions or a slightly longer
COP intervention may lead to more sustained reductions of
stigma stress. It is consistent with this finding that more specific
disclosure-related distress decreased in the COP group during the
intervention period and decreased further during the follow-up
period.
Third, the process of either keeping one’s mental illness a
secret v. disclosure or coming out was a focus of the COP
intervention. Relative to the control group, among COP
participants the tendency to keep their condition secret decreased,
paralleled by increased perceived benefits of disclosure with both
trends continuing in the follow-up period. Although COP does
not aim to make people disclose, these findings point to beneficial
effects of COP because secrecy is a sometimes protective, but often
harmful, long-term coping mechanism.7,18 This is consistent with
results of a recent RCT that evaluated a brief decision aid on
disclosure in workplace settings and found positive effects on
decisional conflict.34
It should be investigated in future studies whether COP is
more effective when delivered to individuals with a long-standing
v. a recent-onset mental illness. Undertaking the programme in
the early stages of one’s mental illness may have the advantage
of fostering adaptive coping styles early on and reducing later
vicious circles of anticipated discrimination, secrecy and social
withdrawal. On the other hand, individuals following a first
episode may not consider themselves ‘mentally ill’ and might
understandably think that coming out with a mental illness is
not a reasonable option for them. For people with a long history
of mental illness the COP programme may work well because
participants are likely to have many experiences with (self-)
labelling, stigma, disclosure and secrecy that they can exchange
in the group sessions. Their identification with the group of
people with mental illness is likely to be stronger and therefore
coming out as someone with a mental illness may be more
intuitive. On the other hand, stigma’s negative impact and
potential consequences such as ‘why try’6 and demoralisation
may be more entrenched and thus harder to change.
Future studies of COP should examine diagnosis as a potential
moderator of intervention effects. Possibly people with less
stigmatised disorders such as anxiety or depression are less
distressed by secrecy and disclosure and respond more promptly
than individuals with psychosis or bipolar disorder. Future trials
should also investigate which factors increase the risk of drop-out
during the intervention. If our very preliminary findings are
replicated, we should make efforts to retain especially those
participants with lower disclosure-related self-efficacy. Finally,
given our recruitment strategy we cannot rule out the possibility
that preferentially those individuals decided to participate who
were already motivated to discuss their decisions regarding secrecy
and disclosure. The high number of participants who had
disclosed to friends and family at baseline supports this view;
on the other hand, in employment settings the reluctance to
disclose was much greater.
Strengths and limitations
Our study has a number of limitations that need to be considered.
First, with 100 participants our study was slightly underpowered
to detect medium effects; this means that our negative findings
regarding COP’s effects on self-stigma and empowerment are
not robust. Second, although the vast majority in both groups
received psychotherapeutic and psychopharmacological treatment,
there was some heterogeneity in the TAU that participants
received. Third, our findings are based on a largely White,
middle-aged, urban Swiss sample and cannot be generalised to
other settings. Fourth, and evident from data in Table 1,
approximately three out of four participants in our study had
decided to disclose their mental illness to friends and family at
baseline. Although the rate was lower for disclosure in
employment settings, future trials will show whether COP has
greater efficacy in samples with lower baseline disclosure rates.
Fifth, our follow-up period was brief and therefore COP’s long-
term effects remain unclear. It could be speculated, for example,
that some of COP’s potential benefits need a number of positive
experiences with coming out and thus more time to materialise.
Our trial also had a number of strengths. As there were few
exclusion criteria, we recruited a sample of people with mental
illness with high external validity. The rates of participants
retained in the trial were high and both groups were comparable
across a wide range of sociodemographic and clinical variables.
Although our trial was not masked, this did not affect findings
because all measures were based on self-report. Fidelity scores
were very high throughout the study. Finally, this is the first
RCTof COP, providing initial evidence that will be complemented
by findings of trials that are currently under way in the USA.
Clinical implications
Many individuals with mental illness experience self-stigma,
stigma-related stress and the dilemma of choosing between
disclosure and secrecy. Previously there were not any specific
interventions to address this concern. Our study provides initial
evidence that COP can support individuals with mental illness
in this domain. If corroborated by future findings, COP as a brief
intervention could be used in clinical as well as mutual support
settings by and for people with mental illness.
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